Our research division, Semantika Research, has been involved in the development of new biomarkers for diagnostic and prognostic models of endometrial carcinoma. The article is published as open access in the journal Frontiers in Oncology: https://www.frontiersin.org/articles/10.3389/fonc.2022.972131/abstract.